Exacerbation biomarkers include quantification of MUC5AB and MUC5AC degradation and increased sialyation during infection, as well as elevated granulocyte-macrophage colony-stimulating factor (GM-CSF) and neutrophil protein calprotectin [37]. This evidence concerns the gene CSF2 and infection.